Center for Quantitative Synthetic BiologyCenter for Synthetic GenomicsCenter for Synthetic BiochemistryCenter for Synthetic MicrobiomeCenter for Genome Engineering and Therapy

Center for Quantitative Synthetic Biology

The Center has now brought together many outstanding young talents in the fields of quantitative biology and synthetic biology. Applying quantitative analysis into synthetic biosystem, the Center focuses on basic scientific problems such as tumor bacterial therapy and drug-resistant bacterial intervention, exploring major scientific problems such as the nature of life and the origin of life, and is actively committed to industrial cooperation and application exploration. The center team currently gathers many cross-complementary research groups including synthetic biology, microbiology, physics, bioinformatics, microfluid analysis chemistry, proteomics, and biomaterials.

Center for Synthetic Genomics

The development of genomics over the past decade has not only given us a comprehensive and in-depth understanding of the genetic material of various organisms, but also enabled us to open up a treasure trove of precious species and genes. Synthetic genomics was fortunately based on this. It aims to better understand the biological nature of the genome and to systematically analyze the biological functions of the entire genome by designing and reengineering the de novo synthesis method, and to give it new features. Research and application. At present, the center has formed an international research team composed of Jie Qing, Qing Qian, etc., from the Institute of Synthetic Biology, Institute of Advanced Biology, Chinese Academy of Sciences, Institute of synthetic biology, Dr. Dai Junchuang, and Dr. Cai Yizhi, the chief professor of Manchester Manst University. Jointly serving as director, the academician of the New York University School of Medicine Jeff Buka (confirmed Chinese name) serves as honorary director and aims to build a world-class research center for synthetic genomics. The main research directions of the center include: 1. Development of gene and gene combinations into use technology; 2. Genome design and analysis; 3. The application of synthetic biology.

Center for Synthetic Biochemistry

The Center for Synthetic Biochemistry is directed by Jay D. Keasling, an member of National Academy of Engineering.It has gathered many talents in the fields of biology and metabolic engineering. Based on synthetic biology, guided by market demand and regional strategy, the center is committed to the development of new synthetic biochemical theories and methods, and the use of cutting-edge synthetic biology technology to transform the natural metabolism that already exists in nature (plants, fungi, animals) Pathways, and the introduction of engineered microorganisms, based on cheap raw materials to prepare valuable natural or non-natural products.

Center for Synthetic Microbiome

Using cutting-edge technologies of synthetic biology, the emerging field of Synthetic Microbiome aims to engineer complex microbial communities to achieve desired function and stability. Rational design and precise modulation of microbial communities holds promise for solving important issues in multiple areas, including human health, sustainable agriculture, etc. The Center for Synthetic Microbiome will create an innovative ecosystem to promote basic research of synthetic microbial communities as well as their applications in medicine, agriculture and bio-manufacturing.

Center for Genome Engineering and Therapy

The mission of Center for Genome Engineering and Therapy (CGET) is developing the cutting-edge approaches to editing, writing and regulating nucleic acids (DNA and RNA) and proteins for human healthcare and therapeutics. The main research directions of the center include: (i)Genome engineering technology: Rewriting human Genome; (ii)Gene therapy and cell therapy: Aging reversal; (iii)Precision Medicine: Genomics and omics analysis for diagnosis.


    Contact Us